Ranbaxy to market Alltech's products in India

Tuesday, 02 September 2003, 19:30 IST
Printer Print Email Email
NEW DELHI: India's pharmaceutical major Ranbaxy Laboratories Ltd. has entered into an alliance with the U.S.-based Alltech Biotechnology (Alltech) to market its animal nutrients products in the country. The Kentucky-based Alltech is a world leader in the animal feed additive business, with an annual turnover of around $200 million. The company is present in 74 countries directly or through representation. Through its marketing alliance with Ranbaxy, Alltech is planning to enter the Indian market with its YeaSacc*1026 Bolus, a highly valued product in the dairy cattle segment, according to a company release Tuesday. With its prominent position in the Indian animal health industry, Ranbaxy expects good potential demand for products such as YeaSacc, which are used to improve the productivity of dairy animals. "The product has a great fit for the Indian market as it boosts milk production by stimulating appetite, improving rumen function and results in increased milk yield and fat percentage," said Chris King, general manager of Alltech in India. "YeaSacc has demonstrated excellent results in numerous local and overseas trials, and the Indian market with its high roughage inclusion in the diet, is ideally suited to benefit from this product," King said in a statement. India is the world's largest milk producer, but the average Indian cattle farmer struggles with poor average milk yield and problems such as poor appetite and low fertility. "The alliance will leverage and integrate the competencies of the Ranbaxy and Alltech, and we expect to gain a leadership position in the market relatively quickly," said Sanjay Chibber, Business Head of Ranbaxy's Animal Health Division. Ranbaxy and Alltech have plans for introducing more products in a phased manner. Ranbaxy's Livestock business of the animal health division is one of the fastest growing businesses among the animal healthcare companies in India. In just three years after starting an exclusive strategic business unit for livestock products, Ranbaxy has catapulted itself into the fifth position. "The new commercial partnership between two leading companies has the potential to improve this current situation," said Ranbaxy.
Source: IANS
siliconindia